Qualigen Therapeutics appoints Graydon Bensler as independent director and audit committee chair

AIxCrypto Holdings, Inc.

Bensler appointed to Board effective Nov 7, 2024; named audit committee chair on Nov 21.
Director Agreement provides $5,000 monthly base fee plus eligibility for equity awards and indemnification.
Bensler is independent under Nasdaq rules; amendment corrects prior 8-K with proper agreement.
Appointment fills Board vacancy and strengthens audit committee oversight.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.